Watch this excellent presentation by Dr Rob Weinkove of the Malaghan Institute, courtesy of Leukaemia & Blood Cancer NZ, on ‘COVID-19 and...
News
Expert advice on preventing infection in multiple myeloma
A global panel of experts convened by the International Myeloma Society has published consensus guidelines and recommendations for the prevention of infection in multiple myeloma, which remains the leading cause of morbidity and mortality in patients despite advances in treatment response.
Dr Ken Romeril – The Medicine Gap
The Medicine Gap was created by a group of concerned New Zealanders who believe the Government must address this country’s escalating...
Seminar: Treatment of newly diagnosed myeloma – when things don’t go to plan
On Demand Webinar by thelimbic live From the comfort of your own desk (or armchair) ... watch the latest event in Myeloma Australia's MAGIC myeloma...
Myeloma NZ End of Year Function
Wellington End of Year Function Date for 2022 to be advised. It is a requirement to be double vaccinated to attend this event.
COVID mortality rate a concern in vaccinated blood cancer patients
By Selina Wellbelove - 15 Nov 2021 Vaccinated patients with blood cancers experiencing breakthrough COVID-19 infections remain at high risk for...
Proactive fatigue screening and management called for in blood cancer patients
A study showing fatigue is common and enduring in non-Hodgkin lymphoma (NHL) survivors has highlighted the need for more proactive screening and...
Covid-19: ‘Not fair’ unvaccinated will force mum with blood cancer to stay ‘locked’ in home for remaining years
Nichola Oakenfull is partially vaccinated against Covid-19, but she’s still scared. The Wellington woman was diagnosed...
New Trial In Relapsed/refractory multiple myeloma
This Phase I trial is now open at Middlemore Hospital in Auckland for t (11,14 ) RRMM patients.
Paediatric oncology parents are pleased with quality of care despite pandemic
This article originally published on The Limbic Most parents of children undergoing active cancer treatment at the RCH Children’s Cancer Centre,...
PVd triplet therapy now on PBS for MM patients after first relapse
Pomalidomide (Pomalyst) in combination with bortezomib and dexamethasone (PVd) will be reimbursed on the PBS from 1 October for patients with...
ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax
People with blood cancers who are immunocompromised are now advised to have a third primary dose of COVID-19 vaccine with an mRNA vaccine. On 8...